Founders Financial Alliance’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
– Sell
-1,757
Closed -$218K – 468
2021
Q2
$218K Buy
1,757
+249
+17% +$33.5K 0.1% 219
2021
Q1
$230K Sell
1,508
-210
-12% -$31.7K 0.11% 202
2020
Q4
$222K Buy
1,718
+1,644
+2,222% +$189K 0.13% 182
2020
Q3
$7K Buy
+74
New +$6.77K ﹤0.01% 877

Other funds holding GH

Founders Financial Alliance's GH Position: Q3 2021 in Review

Founders Financial Alliance sold out of Guardant Health (GH) in Q3 2021, closing a stake of 1,757 shares — an estimated $218K sold.

Founders Financial Alliance first reported a position in GH in Q3 2020 and held it in 4 quarters. The position peaked at $230K in Q1 2021. 374 funds tracked by Wall St. Rank hold GH as of Q3 2021.

  • Founders Financial Alliance reported no remaining Guardant Health position as of Q3 2021 after selling out during the quarter.
  • Founders Financial Alliance sold 1,757 Guardant Health shares in Q3 2021, an estimated $218K.
  • Founders Financial Alliance first reported a position in Guardant Health in Q3 2020 and held it in 4 quarters.
  • Founders Financial Alliance's Guardant Health position peaked at $230K in Q1 2021.
  • 374 funds tracked by Wall St. Rank held Guardant Health as of Q3 2021.

Based on Founders Financial Alliance's 13F filing for Q3 2021, filed 15 Nov 2021.